• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New Tool Helps Countries Eliminate Dog-Mediated Rabies

January 3, 2018
JoAnna Pendergrass, DVM

A research team has developed a planning tool to help countries meet the World Health Organization’s goal of eliminating dog-mediated rabies by 2030.

Rabies is a global health problem transmitted primarily by dogs that causes nearly 60,000 human deaths annually. In many Western and Asian countries, combining mass dog rabies vaccinations with collaborations between human and veterinary medicine has drastically reduced human exposure to rabies. These collaborations focus on educating people about responsible pet ownership, rabies awareness, and post-exposure prophylaxis.

The World Health Organization (WHO) and other related organizations came together in 2016 to set an ambitious goal of eliminating dog-mediated rabies globally by 2030. Reaching this goal would require mass dog rabies vaccination (at least 70% of dog population), mass pre- and post-exposure prophylaxis administration, or both; such measures could be quite costly.

Rabies-endemic countries, particularly those only beginning to implement rabies control efforts, face several barriers to meet the WHO goal. Such barriers include logistical and operational challenges, competing disease priorities, lack of local epidemiological data, and limited availability of tools to determine the resources needed for rabies elimination.

RELATED:

  • Rabies: A One Health Disease
  • Eliminating Canine Rabies From the Western Hemisphere
Advertisement

To delve deeper into a country’s ability to eliminate rabies, a research team comprised of members from the Centers for Disease Control and Prevention (CDC), Washington State University, and Kenya’s Medical Research Institute and Ministry of Health identified 4 key factors affecting a country’s ability to meet the WHO goal:

  • Country development
  • Demand for rabies vaccine
  • Estimated number of vaccinators
  • Cost of dog vaccination programs

The research team also calculated global estimates for resources required to eliminate rabies by 2030. However, the team realized that these estimates were not practical for country-level planning of mass dog rabies vaccinations. Thus, they developed a planning tool that countries can use to help meet the 2030 rabies elimination goal. The research team recently described the tool’s details and usefulness in the CDC’s Emerging Infectious Diseases journal.

Tool Details

The publicly-available tool is designed with the intent to eliminate rabies by 2030, giving countries a reasonable 13-year framework to meet the goal. Each country would input the following country-specific data:

  • Demographic information: human and dog populations, human-to-dog ratio
  • Current percentage of rabies-vaccinated dogs
  • Logistical information: number of available vaccinators, dog vaccination rates, campaign duration
  • Estimated per-dog vaccination cost

The tool also includes a worksheet to help countries estimate the per-dog vaccination cost. Notably, this planning tool has already been used in Haiti and Guatemala.

To demonstrate the tool’s usefulness, the research team used data from 2 mass dog rabies vaccination campaigns in western Kenya. Kenya is actively working toward the rabies elimination goal. Using the tool, the researchers determined that Kenya could meet the goal within 13 years at a cost of $62 million and a per-dog vaccination cost of approximately $1.80.

Researchers hope that developing this tool, “will help stimulate and inform a necessary discussion on strategic planning, resource mo­bilization, and continuous execution of rabies elimination.”

Dr. JoAnna Pendergrass received her Doctor of Veterinary Medicine degree from the Virginia-Maryland College of Veterinary Medicine. Following veterinary school, she completed a postdoctoral fellowship at Emory University’s Yerkes National Primate Research Center. Dr. Pendergrass is the founder and owner of JPen Communications, a medical communications company.


Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement